Company intelligence / Profile preview

BioAI Health

Goffstown, New Hampshire, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

BioAI Health has partnered with clinical diagnostic labs and biopharma companies to deploy AI-powered digital biomarker technologies in oncology, mainly through the PredictX platform. No direct clinical results for drugs, but platform is used for clinical sample analysis and biomarker discovery; recent partnerships suggest active clinical deployment

Therapeutic areas: OncologyOther
Modalities: Digital biomarkerDiagnostic assayGenomic profiling
Industry: Digital Health Medical Devices

Partnerships

Genomic Testing CooperativePharmaceutical and biotechnology company collaborations (not named)Academic cancer centers (not named)

Beyond the preview

Go deeper on BioAI Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAI Health.

Explore the full profile